Xiaoqian Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoqian Liu has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Jue Wang
School of Pharmacy & School of Biological and Food Engineering
10 shared publicationsZhimin Yue
7 shared publicationsJiawei Han
6 shared publicationsWeitao Fang
School of Pharmacy & School of Biological and Food Engineering
6 shared publicationsBaimin Niu
School of Pharmacy & School of Biological and Food Engineering
5 shared publicationsHuizhen Sun
School of Pharmacy & School of Biological and Food Engineering
5 shared publications
Latest Publications
- 2 July 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23  (8) , 4203-4216
Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance
Some drugs undergo gelation during the formulation development process, which not only poses significant challenges to the manufacturing process of solid dosage forms but also significantly restricts the drug dissolution and absorption. Could such gelation be utilized by designing the prescription to overcome the adverse effects and water solubility defect of drugs? Herein, this study attempted to design the self-gelation tablets of indomethacin (IND) by introducing small-molecule ligands and to explore the self-gelation mechanism. As a result, the designed tablets occurred to have spontaneous gelation with a typical 3D structure and viscoelasticity upon contact with a small amount of water, accompanied by amorphization transformation. Such a self-gelation behavior was significantly influenced by the composition ratios, storage temperatures, and medium pH values. In comparison to pure IND tablet, the designed IND-ligand tablets performed significantly increased apparent solubility (>200-fold) and intrinsic dissolution rate (>6000-fold) and maintained the long-term supersaturated dissolution with acid–base interactions, which was revealed by nucleation inhibition, fluorescence quenching, and phase solubility tests. Moreover, the self-gelled tablets significantly enhanced the membrane permeability of IND, demonstrating the potential for promoting oral absorption. Thus, this study revealed the self-gelation mechanism of the tablet combination and confirmed such prescription design involving self-gelation as an efficient solubilization strategy.
- 2 July 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23  (8) , 4203-4216
Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance
Some drugs undergo gelation during the formulation development process, which not only poses significant challenges to the manufacturing process of solid dosage forms but also significantly restricts the drug dissolution and absorption. Could such gelation be utilized by designing the prescription to overcome the adverse effects and water solubility defect of drugs? Herein, this study attempted to design the self-gelation tablets of indomethacin (IND) by introducing small-molecule ligands and to explore the self-gelation mechanism. As a result, the designed tablets occurred to have spontaneous gelation with a typical 3D structure and viscoelasticity upon contact with a small amount of water, accompanied by amorphization transformation. Such a self-gelation behavior was significantly influenced by the composition ratios, storage temperatures, and medium pH values. In comparison to pure IND tablet, the designed IND-ligand tablets performed significantly increased apparent solubility (>200-fold) and intrinsic dissolution rate (>6000-fold) and maintained the long-term supersaturated dissolution with acid–base interactions, which was revealed by nucleation inhibition, fluorescence quenching, and phase solubility tests. Moreover, the self-gelled tablets significantly enhanced the membrane permeability of IND, demonstrating the potential for promoting oral absorption. Thus, this study revealed the self-gelation mechanism of the tablet combination and confirmed such prescription design involving self-gelation as an efficient solubilization strategy.
- Open Access
Solubility, Release Behavior and Membrane Permeability of a Ibuprofen Hydrogel Co-Assembled with N-Methyl-D-Glucosamine
Small-molecule hydrogels have gradually become a research hotspot compared with polymeric hydrogels, but their practical advantages have not been fully realized in the development of pharmaceutical formulations. This study aimed to explore whether the N-methyl-D-glucosamine (GLU) could be introduced to form a ibuprofen (IBU) hydrogel for overcoming its water solubility defect and optimizing its pharmaceutical properties. Such an IBU-GLU hydrogel was prepared by simply mixing IBU with GLU in small-volume deionized water. The formed IBU-GLU hydrogel was characterized by SEM, rheology, DSC, PXRD and FTIR analyses. In addition, the solubility, in vitro release and permeability were also investigated to evaluate the solubilization and permeability-promoting effects. The resulting IBU-GLU hydrogel exhibited a typical 3D structure with excellent viscoelasticity, which relied on the equilibrium of aggregation and dissolution, as well as a good miscibility between IBU and GLU, and self-assembly driven by intermolecular interactions in an aqueous environment. Compared to pure IBU, the IBU solubility of the IBU-GLU hydrogel was significantly improved by 38.4-fold. Furthermore, IBU-GLU hydrogel demonstrated superior release rates and supersaturation ability, which was attributed to its high-energy state and internal molecular complexation. Additionally, compared with the commercially available IBU hydrogel, the prepared IBU-GLU hydrogel significantly accelerated IBU membrane permeation. Thus, this study highlighted that the designed IBU-GLU hydrogel could serve as a feasible approach to enhance the release and permeability of IBU for its druggability optimization.
Open AccessSolubility, Release Behavior and Membrane Permeability of a Ibuprofen Hydrogel Co-Assembled with N-Methyl-D-Glucosamine
Small-molecule hydrogels have gradually become a research hotspot compared with polymeric hydrogels, but their practical advantages have not been fully realized in the development of pharmaceutical formulations. This study aimed to explore whether the N-methyl-D-glucosamine (GLU) could be introduced to form a ibuprofen (IBU) hydrogel for overcoming its water solubility defect and optimizing its pharmaceutical properties. Such an IBU-GLU hydrogel was prepared by simply mixing IBU with GLU in small-volume deionized water. The formed IBU-GLU hydrogel was characterized by SEM, rheology, DSC, PXRD and FTIR analyses. In addition, the solubility, in vitro release and permeability were also investigated to evaluate the solubilization and permeability-promoting effects. The resulting IBU-GLU hydrogel exhibited a typical 3D structure with excellent viscoelasticity, which relied on the equilibrium of aggregation and dissolution, as well as a good miscibility between IBU and GLU, and self-assembly driven by intermolecular interactions in an aqueous environment. Compared to pure IBU, the IBU solubility of the IBU-GLU hydrogel was significantly improved by 38.4-fold. Furthermore, IBU-GLU hydrogel demonstrated superior release rates and supersaturation ability, which was attributed to its high-energy state and internal molecular complexation. Additionally, compared with the commercially available IBU hydrogel, the prepared IBU-GLU hydrogel significantly accelerated IBU membrane permeation. Thus, this study highlighted that the designed IBU-GLU hydrogel could serve as a feasible approach to enhance the release and permeability of IBU for its druggability optimization.
- Open Access
- 16 May 2026
- Published by Elsevier in SSRN Electronic Journal
Incorporation of Molecular Complexation into Novel Etodolac Hydrogels: A Strategy for Dramatic Enhancement of Drug Release
Driven by advances in gel research, pharmaceutical small-molecule hydrogels are gaining significant attention as drug delivery systems. This study explored the viability of designing small-molecule hydrogels as a solubilization approach, using the poorly water-soluble etodolac (ETO) as a model compound. The novel ETO hydrogels were yielded by simple mixing of ETO with biocompatible small-molecule ligands in minimal deionized water. These hydrogels displayed characteristic three-dimensional network structures with pronounced viscoelastic properties. Through comprehensive characterization and molecular simulation analyses, it was demonstrated that hydrogel formation was dependent on three crucial factors: favorable miscibility between ETO and ligands, a dynamic equilibrium between dissolution and aggregation, as well as self-assembly processes fueled by intermolecular interactions in the aqueous phase. Remarkably, the solubility of ETO within these hydrogels exceeded that of pure ETO by over 16-fold. Furthermore, the novel ETO hydrogels demonstrated enhanced release kinetics and supersaturation maintenance capacity, achieving rapid peak concentrations followed by sustained supersaturated release owing to amorphization and molecular complexation. These beneficial characteristics arose from the inherent high-energy state of the hydrogels, as well as the complexation interaction between ETO and the ligand throughout the release process. Overall, this study validated the rational design of small-molecule hydrogel systems as an effective formulation approach to overcome the poor aqueous solubility of challenging ingredients.
- 16 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIncorporation of Molecular Complexation into Novel Etodolac Hydrogels: A Strategy for Dramatic Enhancement of Drug Release
Driven by advances in gel research, pharmaceutical small-molecule hydrogels are gaining significant attention as drug delivery systems. This study explored the viability of designing small-molecule hydrogels as a solubilization approach, using the poorly water-soluble etodolac (ETO) as a model compound. The novel ETO hydrogels were yielded by simple mixing of ETO with biocompatible small-molecule ligands in minimal deionized water. These hydrogels displayed characteristic three-dimensional network structures with pronounced viscoelastic properties. Through comprehensive characterization and molecular simulation analyses, it was demonstrated that hydrogel formation was dependent on three crucial factors: favorable miscibility between ETO and ligands, a dynamic equilibrium between dissolution and aggregation, as well as self-assembly processes fueled by intermolecular interactions in the aqueous phase. Remarkably, the solubility of ETO within these hydrogels exceeded that of pure ETO by over 16-fold. Furthermore, the novel ETO hydrogels demonstrated enhanced release kinetics and supersaturation maintenance capacity, achieving rapid peak concentrations followed by sustained supersaturated release owing to amorphization and molecular complexation. These beneficial characteristics arose from the inherent high-energy state of the hydrogels, as well as the complexation interaction between ETO and the ligand throughout the release process. Overall, this study validated the rational design of small-molecule hydrogel systems as an effective formulation approach to overcome the poor aqueous solubility of challenging ingredients.
- Open Access
Formation and Release Enhancement of a Novel Small-Molecule Hydrogel Containing Sulindac and Meglumine
Up to now, most hydrogel-related studies have been devoted to the preparation of drug-containing macromolecular gels via the introduction of polymer matrices, together with the clarification of their assembly mechanisms and biomedical applications. In contrast, studies concerning the design of small-molecule gel systems remain relatively limited. As gel research progresses, drug small-molecule hydrogels have attracted growing interest for formulation development. This study investigated whether designing a small-molecule hydrogel could serve as an effective solubilization approach for sulindac (SUL)—a nonsteroidal anti-inflammatory drug clinically restricted by its poor aqueous solubility. Then, a SUL small-molecule hydrogel was prepared by straightforward mixing of SUL with biologically safe meglumine (MEG) in a minimal volume of deionized water, which exhibited a characteristic three-dimensional network structure and favorable viscoelastic properties. The characterization and simulation results indicated that the hydrogel formation was contingent upon the SUL-MEG miscibility, dissolution-aggregation equilibrium and intermolecular self-assembly. Consequently, the resulting SUL-MEG hydrogel exhibited 546 times higher solubility compared to the pure SUL. Meanwhile, the SUL-MEG hydrogel demonstrated superior release kinetics and supersaturation capacity, characterized by rapid attainment of peak concentrations and sustained supersaturated release. These enhanced performances were attributed to the high-energy state of the hydrogel itself and the molecular complexation between SUL and MEG. In conclusion, this study presents a feasible formulation strategy for overcoming the poor water solubility of insoluble drugs through the development of small-molecule hydrogel formulations.
Open AccessFormation and Release Enhancement of a Novel Small-Molecule Hydrogel Containing Sulindac and Meglumine
Up to now, most hydrogel-related studies have been devoted to the preparation of drug-containing macromolecular gels via the introduction of polymer matrices, together with the clarification of their assembly mechanisms and biomedical applications. In contrast, studies concerning the design of small-molecule gel systems remain relatively limited. As gel research progresses, drug small-molecule hydrogels have attracted growing interest for formulation development. This study investigated whether designing a small-molecule hydrogel could serve as an effective solubilization approach for sulindac (SUL)—a nonsteroidal anti-inflammatory drug clinically restricted by its poor aqueous solubility. Then, a SUL small-molecule hydrogel was prepared by straightforward mixing of SUL with biologically safe meglumine (MEG) in a minimal volume of deionized water, which exhibited a characteristic three-dimensional network structure and favorable viscoelastic properties. The characterization and simulation results indicated that the hydrogel formation was contingent upon the SUL-MEG miscibility, dissolution-aggregation equilibrium and intermolecular self-assembly. Consequently, the resulting SUL-MEG hydrogel exhibited 546 times higher solubility compared to the pure SUL. Meanwhile, the SUL-MEG hydrogel demonstrated superior release kinetics and supersaturation capacity, characterized by rapid attainment of peak concentrations and sustained supersaturated release. These enhanced performances were attributed to the high-energy state of the hydrogel itself and the molecular complexation between SUL and MEG. In conclusion, this study presents a feasible formulation strategy for overcoming the poor water solubility of insoluble drugs through the development of small-molecule hydrogel formulations.
- Open Access
- 7 February 2026
- Published by Elsevier in SSRN Electronic Journal
Insight into formation and release enhancement of etodolac small-molecule hydrogelsthroughamorphization and molecular complexation
Driven by advances in gel research, limited pharmaceutical small-molecule hydrogels begun to attract attention. However, their potentials were not transformed into practical formulation development. Herein, this study used poorly water-soluble etodolac (ETO) as a model to explore the solubilization feasibility and effective design of such hydrogels. The novel ETO hydrogels were prepared by simply mixing ETO with biocompatible small-molecule ligands in minimal deionized water, exhibiting 3D network structures and pronounced viscoelasticity. Comprehensive characterization and molecular simulations revealed hydrogel formation relied on the favorable ETO-ligand miscibility, dissolution-aggregation equilibrium, and self-assembly driven by intermolecular interactions in aqueous environments. Remarkably, ETO solubility in these hydrogels was over 16-fold higher than pure ETO and they also showed enhanced release kinetics and supersaturation maintenance owing to amorphization and molecular complexation. In summary, this work establishes the design of small-molecule hydrogel systems as a feasible formulation strategy to address the water insolubility of challenging drugs.
- 7 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInsight into formation and release enhancement of etodolac small-molecule hydrogelsthroughamorphization and molecular complexation
Driven by advances in gel research, limited pharmaceutical small-molecule hydrogels begun to attract attention. However, their potentials were not transformed into practical formulation development. Herein, this study used poorly water-soluble etodolac (ETO) as a model to explore the solubilization feasibility and effective design of such hydrogels. The novel ETO hydrogels were prepared by simply mixing ETO with biocompatible small-molecule ligands in minimal deionized water, exhibiting 3D network structures and pronounced viscoelasticity. Comprehensive characterization and molecular simulations revealed hydrogel formation relied on the favorable ETO-ligand miscibility, dissolution-aggregation equilibrium, and self-assembly driven by intermolecular interactions in aqueous environments. Remarkably, ETO solubility in these hydrogels was over 16-fold higher than pure ETO and they also showed enhanced release kinetics and supersaturation maintenance owing to amorphization and molecular complexation. In summary, this work establishes the design of small-molecule hydrogel systems as a feasible formulation strategy to address the water insolubility of challenging drugs.
- 3 July 2025
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 344  (Pt 1) , 126642
Nucleophilic addition triggered fluorescent probe for detection of diphenyl chlorophosphate (DCPP): Real-time application in monitoring the presence of trace amounts in the environment
- 3 July 2025
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 344  (Pt 1) , 126642
Nucleophilic addition triggered fluorescent probe for detection of diphenyl chlorophosphate (DCPP): Real-time application in monitoring the presence of trace amounts in the environment
- 29 April 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22  (6) , 3045-3060
Design of Coamorphous Systems for Flavonoid Components Coformed with Meglumine by Integrating Theory-Model-Experiment Techniques
Flavonoids represent an extensive group of phenolic substances in vegetables, fruits, grains, tea, flowers, etc., which show a variety of biological activities in various nutraceutical, cosmetic, and medicinal fields. Despite demonstrating multifunctional bioactive properties relevant to nutraceutical and pharmaceutical applications, their clinical utilization faces challenges due to their generally low water solubility. This study established a systematic methodology combining computational modeling and experimental validation for developing flavonoid-meglumine (MEG) coamorphous formulations. The initial screening identified 13 flavonoid compounds exhibiting favorable miscibility with MEG from 15 candidates through Hansen solubility parameter analysis. Subsequent molecular dynamics simulations revealed potential hydrogen bond formation in six selected flavonoids (BAI, HES, NAR, KAE, QUE, and ISO) with MEG. Then, six flavonoid coamorphous systems were successfully prepared via the melt-quenching method and characterized by PLM, PXRD, and differential scanning calorimetry. FTIR and radial distribution function analysis results collectively confirmed intermolecular hydrogen bond interactions within these binary systems. In vitro dissolution studies revealed significant solubility/dissolution enhancement in both pH 1.2 HCl and pH 6.8 phosphate buffers, maintaining long-term supersaturation for all six coamorphous formulations. Meanwhile, six flavonoid coamorphous systems had superior stability over individual flavonoid amorphous components, which were attributed to the stronger intermolecular interactions by higher binding energy calculation. These results indicated that the obtained flavonoid coamorphous systems performed a promising application potential in functional products. Importantly, this study presents a novel design framework integrating computational prediction, molecular modeling, and experimental validation for systematic screening of flavonoid coamorphous formulations.
- 29 April 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22  (6) , 3045-3060
Design of Coamorphous Systems for Flavonoid Components Coformed with Meglumine by Integrating Theory-Model-Experiment Techniques
Flavonoids represent an extensive group of phenolic substances in vegetables, fruits, grains, tea, flowers, etc., which show a variety of biological activities in various nutraceutical, cosmetic, and medicinal fields. Despite demonstrating multifunctional bioactive properties relevant to nutraceutical and pharmaceutical applications, their clinical utilization faces challenges due to their generally low water solubility. This study established a systematic methodology combining computational modeling and experimental validation for developing flavonoid-meglumine (MEG) coamorphous formulations. The initial screening identified 13 flavonoid compounds exhibiting favorable miscibility with MEG from 15 candidates through Hansen solubility parameter analysis. Subsequent molecular dynamics simulations revealed potential hydrogen bond formation in six selected flavonoids (BAI, HES, NAR, KAE, QUE, and ISO) with MEG. Then, six flavonoid coamorphous systems were successfully prepared via the melt-quenching method and characterized by PLM, PXRD, and differential scanning calorimetry. FTIR and radial distribution function analysis results collectively confirmed intermolecular hydrogen bond interactions within these binary systems. In vitro dissolution studies revealed significant solubility/dissolution enhancement in both pH 1.2 HCl and pH 6.8 phosphate buffers, maintaining long-term supersaturation for all six coamorphous formulations. Meanwhile, six flavonoid coamorphous systems had superior stability over individual flavonoid amorphous components, which were attributed to the stronger intermolecular interactions by higher binding energy calculation. These results indicated that the obtained flavonoid coamorphous systems performed a promising application potential in functional products. Importantly, this study presents a novel design framework integrating computational prediction, molecular modeling, and experimental validation for systematic screening of flavonoid coamorphous formulations.